#clinical - Techseriesinsight

August 12, 2025
Business Wire
Artificial Intelligence, Biotechnology, Healthcare, News

BostonGene Publishes Landmark Study Providing Clinical and Analytical Validation for Its Multimodal RNA and DNA Assay

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, “Clinical and analytical validation of a combined RNA and DNA...

July 30, 2025
PRNewswire
Healthcare, News

Galaxy Therapeutics Opens New Manufacturing Facility to Support Global Commercialization

Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced the official opening of its new 9,200 square foot (855 m²) facility designed...

Illustration of stent inside coronary artery

July 10, 2025
Business Wire
Biotechnology, Healthcare, News

XyloCor Doses First Patient in Transformative Gene Therapy Trial

XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 trial, designed to...

July 1, 2025
PRNewswire
Biotechnology, Healthcare, News

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and...

Pipette adding liquid to petri dish in lab with test tubes behind.

June 30, 2025
PRNewswire
Healthcare, News

Oncolytics Biotech Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Andrew Aromando as Chief Business Officer. Mr. Aromando most recently served as...

June 24, 2025
PRNewswire
Biotechnology, Healthcare, News

Pharmactive’s Saffron Extract Proven to Boost Mood and Emotional Wellness

Results from a new, large-scale clinical study demonstrate Pharmactive Biotech Products, S.L.U.’s flagship saffron extract Affron could help lift the mood in people suffering from mild depressive symptoms. Building on ten previous...

June 18, 2025
PRNewswire
Healthcare

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials

The START Center for Cancer Research (“START”), the world’s largest early-phase community-based cancer trial site network, today announced the launch of the START Hope Hub, a powerful new digital patient...

June 17, 2025
PRNewswire
Healthcare

Children’s Hospital of Philadelphia Researchers Spotlight Adults with Hypoplastic Left Heart Syndrome (HLHS) Thriving Without Transplants

Researchers at Children’s Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who underwent complex reconstructive surgery for hypoplastic left heart syndrome as newborns. In...

June 16, 2025
PRNewswire
Biotechnology

Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation

Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company redefining treatment paradigms through inflammation-targeted and resilience-driven therapies, today announced the successful completion of its first-in-human Phase 1 clinical trial evaluating HT-4253...

June 13, 2025
PRNewswire
Biotechnology

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

On June 12, Keymed Biosciences Inc. (HKEX: 02162) announced that Prof. Jun Shi’s research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology,...